TGFB1 and neoplasm: The final derivation of the TGFβ-EMT signature was created by applying the cell line derived signature to several patient-derived tumor specimen cohorts, then identifying and removing genes that exhibit opposite behavior between cell lines and human tumors; thus, minimizing variations due to in vitro manipulations.